Sign up for email alerts of latest news, events, new funding opportunities and more.
8 May 2019
MRC-supported scientists are among the 50 distinguished medical researchers elected as Fellows of the Academy of Medical Sciences.
1 Nov 2018
Over the recent years, advances in technology have allowed many more diagnostic tests to be carried out at the patient’s bedside rather than the laboratory bench.
22 Oct 2018
A new trial has found that treating the prostate with radiotherapy alongside standard treatment led to a three-year survival rate of 81%, compared to 73% in those who didn’t receive radiotherapy, for some men with advanced prostate cancer.
3 Oct 2018
The MRC is delighted to congratulate Professor Sir Gregory Winter, a former deputy director of the MRC Laboratory of Molecular Biology, Cambridge, on being awarded the Nobel Prize in Chemistry jointly with Frances H. Arnold and George P. Smith.
28 Sep 2018
Two MRC projects have been shortlisted for the 2018 Newton Prize, an annual £1 million fund awarded for the best research or innovation that promotes the economic development and social welfare of developing countries.
27 Sep 2018
Adaptive clinical trials are transforming the efficiency of drug development and the MRC has played a crucial role in implementing this innovative method into the UK clinical trials landscape. This trial methodology helps to deliver the right treatment to the right patient faster than ever before.
25 Sep 2018
MRC-funded scientists have delivered the first ever treatment in the UK using a Magnetic Resonance Linear Accelerator (MR Linac) machine.
17 Sep 2018
Over 500 new gene regions that influence people’s blood pressure have been discovered in the largest global genetic study of blood pressure to date. The research was co-funded by the MRC.
5 Jul 2018
Today, the NHS celebrates its 70th birthday. Since its launch on 5 July 1948, the NHS has utilised advances in medical science to deliver a free healthcare service for all.
30 May 2018
MRC-funded research from Sir Aaron Klug’s lab at MRC LMB underpins a historic gene editing trial.